This invention concerns the use of a compound of formula (I), a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein Z is halo; C1-6alkyl; C1-6alkyl substituted with hydroxy, carboxyl, cyano, amino, mono -or di(C1-6alkyl)amino, aminocarbonyl, mono -or di(C1-6alkyl)aminocarbonyl, C1-6alkyloxycarbonyl or C1-6alkyloxy; polyhaloC1-4alkyl; C1-4alkyloxy; cyano; amino; aminocarbonyl; mono -or di(C1-6alkyl)aminocarbonyl; C1-6alkyloxycarbonyl; C1-6alkylcarbonyloxy; H2N-S(=O)2-; mono -or di(C1-6alkyl)amino-S(=O)2; -C(=N-Rx)NRyRz; Q is an optionally substituted carbocycle or an optionally substituted heterocycle; L is substituted phenyl or an optionally substituted monocyclic 5 or 6-membered partially saturated or aromatic heterocycle or a bicyclic partially saturated or aromatic heterocycle; aryl is optionally substituted phenyl; for the manufacture of a medicament for the prevention or the treatment of diseases mediated through TNF-α and/or IL-12.
本发明涉及使用式(I)的化合物,N-氧化物,药学上可接受的加成盐,季
铵盐及其立体化异构体,其中Z为卤素; C1-6烷基; C1-6烷基取代羟基,羧基,
氰基,
氨基,单-或二(C1-6烷基)
氨基,
氨基甲酰基,单-或二(C1-6烷基)
氨基甲酰基,C1-6烷氧基羰基或C1-6烷氧基; 多卤代C1-4烷基; C1-4烷氧基;
氰基;
氨基;
氨基甲酰基; 单-或二(C1-6烷基)
氨基甲酰基; C1-6烷氧基羰基; C1-6烷基羰基氧;
H2N-S(=O)2-; 单-或二(C1-6烷基)
氨基-S(=O)2; -C(=N-Rx)NRyRz; Q为可选择取代的碳环或可选择取代的杂环; L为取代苯基或可选择取代的单环5或6成员部分饱和或芳香杂环或双环部分饱和或芳香杂环; 芳基为可选择取代的苯基; 用于制造预防或治疗通过TNF-α和/或IL-12介导的疾病的药物。